WilesCMClarkeCRAIrwinHPEdgarEFSwanAB. Hyperbaric oxygen in multiple sclerosis; a double blind study. Br Med J1986; 292: 367–71
2.
BarnesMPBatesDCartlidgeNEFFrenchJMShawDA. Hyperbaric oxygen in multiple sclerosis: Short term results of a placebo controlled, a double blind trial. Lancet1985; i: 297–300
3.
BoschettyVCernochJ. Aplikace kysliku za pretlaku nekterych, Neurologickych Anemocneni. Bratisl Lek Lesty1970; 53: 298–302
4.
WarrenJSackstederMRThuningCA. Oxygen immunosuppression: Modification of experimental allergic encephalomyelitis in rodents. J Immunol1978; 121: 315–20
5.
JamesPB. Evidence of subacute fat embolism as the cause of multiple sclerosis. Lancet1982; i: 380–5
6.
FischerBHMarksMReichT. Hyperbaric oxygen treatment of multiple sclerosis. A randomised, placebo-controlled, double blind study. N Engl J Med1983; 308: 181–6
7.
JamesPB. Hyperbaric oxygen for multiple sclerosis. World Medicine1983; 18: 33–4
8.
MasseyEWSheltonDLPactV. Hyperbaric oxygen in multiple sclerosis: Double blind crossover study of 18 patients. Neurology1985; 35 (Suppl 1): 104
9.
MurthyKMMauricePBWilmethJB. Double-blind randomised study of hyperbaric oxygen versus placebo in multiple sclerosis. Neurology1985; 35 (Suppl 1): 104
10.
SlaterGEAndersonDAShermanREttingerMGHaglinJHitchcockC. Hyperbaric oxygen in multiple sclerosis: A double blind control study. Neurology1985; 35 (Suppl 1): 315
